Uwell Biopharma, Inc. (TPEX:7902)

Taiwan · Delayed Price · Currency is TWD

35.90

-0.05 (-0.14%)

At close: Sep 7, 2026

Uwell Biopharma Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.04	0.01	0.08	0.08	0.18	0.14
Net Debt / Equity Ratio	-0.90	-0.94	-0.66	-0.74	-0.42	-0.63
Net Debt / EBITDA Ratio	3.79	4.85	1.06	1.71	0.41	1.16
Net Debt / FCF Ratio	4.23	5.81	1.32	1.83	0.54	1.26
Asset Turnover	0	0	0.01	-	-	-
Quick Ratio	14.15	24.57	4.48	9.52	2.83	6.28
Current Ratio	14.26	24.61	4.53	9.61	2.90	6.68
Return on Equity (ROE)	-26.77%	-33.18%	-48.06%	-59.77%	-62.47%	-69.31%
Return on Assets (ROA)	-16.40%	-20.10%	-27.88%	-33.99%	-37.52%	-33.39%
Return on Capital Employed (ROCE)	-24.30%	-20.30%	-66.30%	-44.40%	-98.90%	-52.00%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Buyback Yield / Dilution	-66.46%	-30.97%	-31.62%	-55.95%	-141.86%	-11.16%